Beneficial impact of vitamin D could alleviate symptoms and treat MS

NewsGuard 100/100 Score

Glasgow GP Dr Tom Gilhooly is at the forefront of an exciting new treatment for sufferers of MS. He comments ‘Scotland has the greatest incidence of Multiple Sclerosis in the world – and has more to gain than any other country from new developments such as CCSVI.’

CCSVI (Chronic Cerebrospinal Venous Insufficiency) is now an internationally recognised condition which has been found more commonly in MS patients. Gilhooly explains ‘We need more research to establish if treating CCSVI will improve outcomes in MS, but the theory does make sense. Leakage of iron from leaky veins could increase immune activity and contribute to breakdown of the blood brain barrier. Also MS lesions tend to occur round veins which makes sense if CCSVI is present. It’s early days, but this could be one of the greatest medical breakthroughs of the early 21st century.’

Gilhooly has one of the largest MS private practices in the UK, based at the Essential Health Clinic in Glasgow. There are plans to open a similar centre in London and they are actively seeking to offer scanning services for CCSVI in both London and Glasgow at some point later in 2010.

Gilhooly continues ‘The beneficial impact of vitamin D, antioxidants and omega-3 also fit the CCSVI hypothesis, and could be used to alleviate the symptoms and treat MS. The Doppler ultra sound scan required to show the CCSVI abnormalities has been specially adapted and we hope to have an ultrasound technician fully trained later this summer.’

The cost of the scans in the UK is still to be finalised. Gilhooly and his team are also liaising with intervention radiologists to develop treatment centres around the UK.

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Vitamin D receptor presence in breast cancer tumors linked to better survival outcomes